Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Assets (2024 - 2025)

Historic Assets for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $6.7 million.

  • Kairos Pharma's Assets changed N/A to $6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Kairos Pharma reported Assets of $6.7 million as of Q2 2025.
  • Kairos Pharma's Assets' 5-year high stood at $7.9 million during Q1 2025, with a 5-year trough of $5.0 million in Q3 2024.